Compare Agilent Technologies Inc (A) vs Avalanche Treasury Corporation Class A Common Stock (AVAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Avalanche Treasury Corporation Class A Common Stock — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Avalanche Treasury Corporation Class A Common Stock trades at $0.34 (market cap $14.82M). The key difference: Agilent Technologies Inc is far larger — about 2834× Avalanche Treasury Corporation Class A Common Stock's market cap, and Agilent Technologies Inc pays a 0.69% dividend while Avalanche Treasury Corporation Class A Common Stock pays none. Which is the better fit depends on your goals.
| A | AVAT | |
|---|---|---|
Market Cap | $42.00B | $14.82M |
Sector | Health | Financials |
52-Week High | $157.20 | $10.75 |
52-Week Low | $110.24 | $0.30 |
Enterprise Value | $43.55B | $14.82M |
Dividend Yield | 0.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
AVAT trades at $0.33, down 4.35% on the day, with a bearish technical signal from moving averages. The company reported a net income of $8.28 million for 2025, yet shows negative operating cash flow of -$930,710. Recent news highlights its Nasdaq listing, positioning it as an operating company focused on capital allocation within its ecosystem, attracting attention from major financial media.
The outlook is mixed; low P/E of 12 and P/B of 0.4 suggest undervaluation, but negative cash flow and ROA of -7.25% raise sustainability concerns. Risks include execution challenges in capital deployment and market volatility, while institutional interest may grow post-listing, offering potential upside if operational metrics improve.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Avalanche Treasury Corporation Class A Common Stock
Avalanche Treasury Corp operates as a digital asset treasury company focused on holding and managing digital asset investments. The company was founded on September 22, 2025, and is headquartered in New York, NY.
Read more on AVAT →
